NeoImmuneTech

네오이뮨텍 · 950220

Industrials Commercial Services · KOSDAQ

Small-cap

Market cap US$60.9M (₩84B)

Overview

Company summary coming soon.

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$48.3
▼ −46.6% YoY
Operating profit · FY2025
−US$12.8K
Loss narrowed
Net income · FY2025
−US$16.2K
Loss narrowed

Revenue

  • FY2023US$0
  • FY2024US$90.5
  • FY2025US$48.3

Operating profit

  • FY2023−US$30.9K
  • FY2024−US$21.3K
  • FY2025−US$12.8K

Net income

  • FY2023−US$29.6K
  • FY2024−US$21.7K
  • FY2025−US$16.2K

Key ratios (FY2025)

ROE
-54.2%
Debt/Eq
38.6%
Op. margin
-26596.6%
Net margin
-33531.5%
Rev. YoY
▼ −46.6%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.